146 related articles for article (PubMed ID: 35137367)
21. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
[TBL] [Abstract][Full Text] [Related]
22. [Interaction between SARS-CoV-2 and Host Innate Immunity].
Duan XQ; Xie H; Chen LM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
[TBL] [Abstract][Full Text] [Related]
23. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
Rabaan AA; Al Mutair A; Alhumaid S; Al Alawi Z; Al Mohaini M; Alsalman AJ; Fawzy M; Al-Tawfiq JA; Almahmoud S; Alfouzan W; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Khan Z; Mitra S; Emran TB; Dhama K
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5947-5964. PubMed ID: 34661254
[TBL] [Abstract][Full Text] [Related]
24. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
25. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
26. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
[TBL] [Abstract][Full Text] [Related]
27. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
[TBL] [Abstract][Full Text] [Related]
28. Systematic Review of Clinical Insights into Novel Coronavirus (CoVID-19) Pandemic: Persisting Challenges in U.S. Rural Population.
Lakhani HV; Pillai SS; Zehra M; Sharma I; Sodhi K
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32549334
[TBL] [Abstract][Full Text] [Related]
29. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
30. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
[TBL] [Abstract][Full Text] [Related]
31. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
32. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.
Gadi N; Wu SC; Spihlman AP; Moulton VR
Front Immunol; 2020; 11():2147. PubMed ID: 32983176
[TBL] [Abstract][Full Text] [Related]
33. Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: Screening of targets and understanding pathogenesis.
Khan AA; Jain SK; Rai M; Panda S
Comput Struct Biotechnol J; 2022; 20():4351-4359. PubMed ID: 35965662
[TBL] [Abstract][Full Text] [Related]
34. Deep-HPI-pred: An R-Shiny applet for network-based classification and prediction of Host-Pathogen protein-protein interactions.
Tahir Ul Qamar M; Noor F; Guo YX; Zhu XT; Chen LL
Comput Struct Biotechnol J; 2024 Dec; 23():316-329. PubMed ID: 38192372
[TBL] [Abstract][Full Text] [Related]
35. Optimized network based natural language processing approach to reveal disease comorbidities in COVID-19.
Duman ET; Tuna G; Ak E; Avsar G; Pir P
Sci Rep; 2024 Jan; 14(1):2325. PubMed ID: 38282038
[TBL] [Abstract][Full Text] [Related]
36. A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.
Zahoránszky-Kőhalmi G; Siramshetty VB; Kumar P; Gurumurthy M; Grillo B; Mathew B; Metaxatos D; Backus M; Mierzwa T; Simon R; Grishagin I; Brovold L; Mathé EA; Hall MD; Michael SG; Godfrey AG; Mestres J; Jensen LJ; Oprea TI
J Chem Inf Model; 2022 Feb; 62(3):718-729. PubMed ID: 35057621
[TBL] [Abstract][Full Text] [Related]
37. Inflammaging: The lesson of COVID-19 pandemic.
Bonafè M; Olivieri F
Mech Ageing Dev; 2022 Jul; 205():111685. PubMed ID: 35595122
[No Abstract] [Full Text] [Related]
38. The race to understand immunopathology in COVID-19: Perspectives on the impact of quantitative approaches to understand within-host interactions.
Gazeau S; Deng X; Ooi HK; Mostefai F; Hussin J; Heffernan J; Jenner AL; Craig M
Immunoinformatics (Amst); 2023 Mar; 9():100021. PubMed ID: 36643886
[TBL] [Abstract][Full Text] [Related]
39. Challenges and perspectives in research and teaching of host pathogen interaction topics: new post-pandemic times to Brazil and other South American countries.
Ramírez MI; Ruiz RC; Nogueira-Melo GA; Miletti LC; Cortez M; Negri M; Palmisano G; González J
Mem Inst Oswaldo Cruz; 2023; 118():e220212. PubMed ID: 37222308
[TBL] [Abstract][Full Text] [Related]
40. Learning lessons about lesson-learning: Covid complexity.
Paton C
Health Econ Policy Law; 2023 Jan; 18(1):104-110. PubMed ID: 35698814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
